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Introduction
Thalassaemia major (TM) affects hundreds of thousands
of patients worldwide but only a minority have access to
regular blood transfusion and chelation therapy. Cardio-
vascular magnetic resonance (CMR) T2* measurement
provides an accurate, reproducible measurement of car-
diac iron which is the cause of heart failure and early
death in many transfused TM patients. This technique
has been adopted as part of routine management in
many countries where survival is now approaching nor-
mal but little is known about the severity and effects of
myocardial iron loading in different geographical
regions.
Purpose
The aim of this study was to describe the burden of dis-
ease of myocardial siderosis (measured by T2*) in differ-
ent populations throughout the world and to assess the
relationship between T2* and outcome such as heart
failure and cardiac death.
Methods
34 worldwide centres were involved in this survey of
3376 patients from Europe, the Middle East, North
America, South America, North Africa, Australia and
Asia. Anonymised data on myocardial T2* values were
analysed in conjunction with clinical outcomes (heart
failure and death).
Results
Overall, 57.5% of patients had no significant iron loading
(T2* >20ms), 22.6% had moderate cardiac iron
(10ms<T2*≤20ms) and 19.9% had severe cardiac iron
(T2* ≤10ms) at baseline. The lowest burden of iron was
found in North Africa, North and South America with
an intermediate level in Australia, Europe and the Mid-
d l eE a s tb u tah i g hp r o p o r t i o no fp a t i e n t s( > 5 0 % )i n
South-East Asia had cardiac iron (T2* >20ms) at base-
line. At the time of the first scan, 100 patients (3.3%)
had confirmed heart failure, the majority of whom
(77.0%) had myocardial T2* <10ms with almost all
(99%) having T2* <20ms. There were 113 patients who
subsequently developed heart failure. 92.0% of these had
T2* <10ms and 99.1% had a T2* <20ms. There were
39 deaths. Cardiac T2* values were <10ms in 79.5%,
with 92.3% <20ms.
Conclusions
Even in this well-treated cohort with access to transfu-
sion, chelation and CMR, there is a large proportion of
TM patients with moderate to severe cardiac iron load-
ing. Low T2* (<10ms) is associated with cardiac failure
and death. There is a huge unmet worldwide need in
terms of access to specialist medical care (including
transfusion and chelation therapy) together with
advanced monitoring techniques (such as CMR).
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